Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 90.30
-3.60 (-3.83%)
At close: Mar 12, 2026
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.46 billion as of March 12, 2026. Its market cap has increased by 33.60% in one year.
Market Cap
1.46B
Enterprise Value
1.36B
Revenue
96.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
90.30
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.46B, an increase of 650.13%. That is a compound annual growth rate of 11.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 1.52B | -9.33% |
| Dec 30, 2025 | 1.68B | 64.05% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 265.72B |
| Novartis AG | 239.09B |
| Galderma Group AG | 36.26B |
| Lonza Group AG | 34.87B |
| Tecan Group AG | 1.60B |
| Aevis Victoria | 1.18B |
| Kuros Biosciences AG | 1.15B |
| SKAN Group AG | 1.10B |